Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by hydrocarbsson Sep 02, 2019 10:36am
97 Views
Post# 30088041

RE:Some sources for due diligence

RE:Some sources for due diligenceHow does a company with the technological promise that TLT has get out of these share price doldrums?

Can TLT not get institutional investors and mutual funds to buy it's stock? 

No, the vast majority of institutional investors cannot buy penny stocks.  The fiduciary requirements preclude them from buying stocks that list on the OTC or the Venture exchange.

To get institutional investment, a company needs to be listed on a higher tier exchange, like Nasdaq.

One of the requirements for listing is multi-millions of $ in the companies bank acct and a share price of at least $4.00

With this recent financing, the share price will approach 300,000,000 when all the warrants are exercised.

A share price of $4.00 per each of the 300,000,000 shares would mean a market capitalization of $1.2 Billion.

Considering that the current market capitalization is $45 Million, that's a long way to go. 

TLT has no path or currently laid out plan to achieve this.
Bullboard Posts